2006Progress in Veterinary MedicineRequires access

Preparation of Nucleic Acid Vaccine and Immune Tests of Canine parvovirus

Wei Qiu, Fan Quan-shui, Zuosheng Li, Yang Mei-feng, Ying Zheng, LI Li-hong, Wang Shuang-yin, Li Jiang, Xianzhu Xia

Open publisher page 0 citations

Abstract

The VP1 gene of Canine parvovirus was amplified by PCR and digested by BamHⅠ and NotⅠ,and was cloned into pIRESneo expressing vector.Recombinant plasmid pIRESVP1 was extracted and digested with enzymes and sequenced to confirm its rightness.Six dogs were injected at 9 months old with increasing doses of pIRESVP1 or pIRESneo and saline.All dogs were challenged with virulent CPV after the third injection.NAV vaccinated dogs serum showed a high IgG titer after the second injection and six dogs were protected against infection,while the control dogs were fully susceptible.This study demonstrated that NAV of CPV can protect dogs against virulent CPV.

About this research paper

What this paper is about

The VP1 gene of Canine parvovirus was amplified by PCR and digested by BamHⅠ and NotⅠ,and was cloned into pIRESneo expressing vector.Recombinant plasmid pIRESVP1 was extracted and digested with enzymes and sequenced to confirm its rightness.Six dogs were injected at 9 months old with increasing doses of pIRESVP1 or pIRESneo and saline.All dogs were challenged with virulent CPV after the third injection.NAV vaccinated dogs serum showed a high IgG titer after the second injection and six dogs were protected against infection,while the control dogs were fully susceptible.This study demonstrated that NAV of CPV can protect dogs against virulent CPV.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The VP1 gene of Canine parvovirus was amplified by PCR and digested by BamHⅠ and NotⅠ,and was cloned into pIRESneo expressing vector.Recombinant plasmid pIRESVP1 was extracted and digested with enzymes and sequenced to confirm its rightness.Six dogs were injected at 9 months old with increasing doses of pIRESVP1 or pIRESneo and saline.All dogs were challenged with virulent CPV after the third injection.NAV vaccinated dogs serum showed a high IgG titer after the second injection and six dogs were protected against infection,while the control dogs were fully susceptible.This study demonstrated that NAV of CPV can protect dogs against virulent CPV.

Key concepts: Canine parvovirus, Virology, Virulence, Titer, Recombinant DNA, Parvovirus, Nucleic acid, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation of Nucleic Acid Vaccine and Immune Tests of Canine parvovirus — Research Paper | ScholarLens